Dr Agarwal’s Health Care Ltd provides complete eye care services, including refractive, cataract, surgical and non-surgical treatments, and sells opticals, lenses, and other eye care accessories and related prodcuts.
As per CRISIL report, in Fiscal 2024, the company has 25% share in the eye care market. During Fiscal 2024, it has served 2.13 million patients and performed 220,523 surgeries.
The company catergoized its facility as primary (non-surgical eye care), secondary (surgical), and teritary facilities (super-specialty surgical facilities and three centres of excellence COEs). As of Sep 30, 2024, it has 28 hubs (teritary facilities), 53 primary facilities, and 112 secondary facilities.
Dr. Agarwal’s IPO Details
| IPO Opening Date | 29th Jan 2025 |
| IPO Closing Date | 31st Jan 2025 |
| Issue Price | ₹ 382 to 402 Per Share |
| Market Lot | 35 Shares |
| 1 Lot Amount | ₹ 14070 |
| Small HNI Lot | ₹ 2 to10 Lakhs |
| Big HNI Lot | ₹ 10 + Lakhs |
| Issue Size | ₹ 3027.26 Cr |
| Offer for sale | ₹ 2727.26 Cr |
| Fresh Issue | ₹ 300 Cr |
| IPO Listing at | BSE/SME |
| Allotment Date | 3rd Feb 2025 |
| Refund Initiation | 4th Feb 2025 |
| Credit Of Shares to Demat Account | 4th Feb 2025 |
| Listing Dates | 5th Feb 2025 |
| Allotment Status check at BSE | Click here |
| Allotment Status check at NSE | Click here |